secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001104659-23-071180
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel annual meeting results: equity plan increase approved, directors re-elected, preferred dividend declared
--------------------------------------------------------------------------------

- Stockholders approved 900,000-share increase to 2018 Equity Incentive Plan.
- Spiro Rombotis and Dr. Brian Schwartz re-elected as Class 2 directors for term to 2026.
- RSM US LLP ratified as independent auditor for FY2023.
- Advisory vote on executive compensation passed (52% support with many abstentions and broker non-votes).
- Board declared $0.15/share quarterly dividend on preferred stock (CYCCP), payable Aug 1 to holders of record July 21.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923071180/0001104659-23-071180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923071180/tm2318711d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-071180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer